These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27237318)

  • 21. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
    Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
    Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
    Huanna T; Tao Z; Xiangfei W; Longfei A; Yuanyuan X; Jianhua W; Cuifang Z; Manjing J; Wenjing C; Shaochuan Q; Feifei X; Naikang L; Jinchao Z; Chen W
    Mol Carcinog; 2015 Oct; 54(10):1159-71. PubMed ID: 24962947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin.
    Park JH; Katagiri T; Chung S; Kijima K; Nakamura Y
    Neoplasia; 2011 Apr; 13(4):320-6. PubMed ID: 21472136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer.
    Wang OH; Azizian N; Guo M; Capello M; Deng D; Zang F; Fry J; Katz MH; Fleming JB; Lee JE; Wolff RA; Hanash S; Wang H; Maitra A
    PLoS One; 2016; 11(3):e0152300. PubMed ID: 27023625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nox4-derived ROS signaling contributes to TGF-β-induced epithelial-mesenchymal transition in pancreatic cancer cells.
    Hiraga R; Kato M; Miyagawa S; Kamata T
    Anticancer Res; 2013 Oct; 33(10):4431-8. PubMed ID: 24123012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer.
    Han T; Jiao F; Hu H; Yuan C; Wang L; Jin ZL; Song WF; Wang LW
    Oncotarget; 2016 Mar; 7(10):11194-207. PubMed ID: 26848980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antagonism of microRNA-99a promotes cell invasion and down-regulates E-cadherin expression in pancreatic cancer cells by regulating mammalian target of rapamycin.
    Li D; Li X; Cao W; Qi Y; Yang X
    Acta Histochem; 2014 Jun; 116(5):723-9. PubMed ID: 24461517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer.
    Seshacharyulu P; Ponnusamy MP; Rachagani S; Lakshmanan I; Haridas D; Yan Y; Ganti AK; Batra SK
    Oncotarget; 2015 Mar; 6(7):5164-81. PubMed ID: 25686822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo.
    Zhou J; Song S; He S; Wang Z; Zhang B; Li D; Zhu D
    Int J Mol Med; 2013 Sep; 32(3):653-60. PubMed ID: 23846297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways.
    Vasseur R; Skrypek N; Duchêne B; Renaud F; Martínez-Maqueda D; Vincent A; Porchet N; Van Seuningen I; Jonckheere N
    Biochim Biophys Acta; 2015 Dec; 1849(12):1375-84. PubMed ID: 26477488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex.
    von Burstin J; Eser S; Paul MC; Seidler B; Brandl M; Messer M; von Werder A; Schmidt A; Mages J; Pagel P; Schnieke A; Schmid RM; Schneider G; Saur D
    Gastroenterology; 2009 Jul; 137(1):361-71, 371.e1-5. PubMed ID: 19362090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.
    Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J
    Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CUB-domain containing protein 1 represses the epithelial phenotype of pancreatic cancer cells.
    Miura S; Hamada S; Masamune A; Satoh K; Shimosegawa T
    Exp Cell Res; 2014 Feb; 321(2):209-18. PubMed ID: 24384474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycosyltransferase Gene Expression Identifies a Poor Prognostic Colorectal Cancer Subtype Associated with Mismatch Repair Deficiency and Incomplete Glycan Synthesis.
    Noda M; Okayama H; Tachibana K; Sakamoto W; Saito K; Thar Min AK; Ashizawa M; Nakajima T; Aoto K; Momma T; Katakura K; Ohki S; Kono K
    Clin Cancer Res; 2018 Sep; 24(18):4468-4481. PubMed ID: 29844132
    [No Abstract]   [Full Text] [Related]  

  • 35. NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer.
    Kumar S; Das S; Rachagani S; Kaur S; Joshi S; Johansson SL; Ponnusamy MP; Jain M; Batra SK
    Oncogene; 2015 Sep; 34(37):4879-89. PubMed ID: 25531332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells.
    Lee J; Lee J; Yun JH; Jeong DG; Kim JH
    Tumour Biol; 2016 Sep; 37(9):12193-12202. PubMed ID: 27230679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin.
    Inaguma S; Kasai K; Ikeda H
    Oncogene; 2011 Feb; 30(6):714-23. PubMed ID: 20972463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The glycoprotein mucin-1 negatively regulates GalNAc transferase 5 expression in pancreatic cancer.
    Caffrey T; Sagar S; Thomas D; Lewallen ME; Hollingsworth MA; Radhakrishnan P
    FEBS Lett; 2019 Oct; 593(19):2751-2761. PubMed ID: 31283009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of
    Kurita T; Thi TN; Koi C; Murakami M; Kagami S; Izumi H; Hachisuga T
    Anticancer Res; 2017 Jul; 37(7):3905-3910. PubMed ID: 28668893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer.
    Yang J; Zhang X; Zhang Y; Zhu D; Zhang L; Li Y; Zhu Y; Li D; Zhou J
    J Exp Clin Cancer Res; 2016 Feb; 35():26. PubMed ID: 26842802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.